1.
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, mult...
by Sibbing, Dirk
The Lancet (British edition), 2017-10-14, Vol.390 (10104), p.1747-1757
2.
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled...
by Costa, Francesco, MD
The Lancet (British edition), 2017, Vol.389 (10073), p.1025-1034
3.
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled tr...
by Dewilde, Willem JM, Dr
The Lancet (British edition), 2013, Vol.381 (9872), p.1107-1115
4.
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
by Connolly, S
The American heart journal, 2006, Vol.151 (6), p.1187-1193
5.
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLAT...
by Wallentin, Lars, Prof
The Lancet (British edition), 2010, Vol.376 (9749), p.1320-1328
6.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data
by Li, Jing, PhD
The Lancet (British edition), 2015, Vol.385 (9966), p.441-451
7.
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
by Stone, Gregg W, Dr
The Lancet (British edition), 2013, Vol.382 (9892), p.614-623
8.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre,...
by Ohman, E Magnus, Dr Prof
The Lancet (British edition), 2017, Vol.389 (10081), p.1799-1808
9.
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial
by Derdeyn, Colin P, Prof
The Lancet (British edition), 2014, Vol.383 (9914), p.333-341
10.
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
by Cannon, Christopher P, Dr
The Lancet (British edition), 2010, Vol.375 (9711), p.283-293
11.
Paraoxonase-1 is a major determinant of clopidogrel efficacy
by Bouman, Heleen J
Nature medicine, 2011-01, Vol.17 (1), p.110-U287
12.
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURREN...
by Mehta, Shamir R, Dr
The Lancet (British edition), 2010, Vol.376 (9748), p.1233-1243
13.
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
by Mega, Jessica L, Dr
The Lancet (British edition), 2010, Vol.376 (9749), p.1312-1319
14.
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
by Roberts, Jason D, MD
The Lancet (British edition), 2012, Vol.379 (9827), p.1705-1711
15.
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised cont...
by Montalescot, Gilles, Prof
The Lancet (British edition), 2009, Vol.373 (9665), p.723-731
16.
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
by Collet, Jean-Philippe, MD
The Lancet (British edition), 2009, Vol.373 (9660), p.309-317
17.
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE...
by Connolly, S
The Lancet (British edition), 2006, Vol.367 (9526), p.1903-1912
18.
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised...
by Bøtker, Hans Erik, Prof
The Lancet (British edition), 2010, Vol.375 (9716), p.727-734
19.
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective ana...
by Sørensen, Rikke, Dr
The Lancet (British edition), 2009, Vol.374 (9706), p.1967-1974
20.
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline charact...
by James, Stefan
The American heart journal, 2009-04, Vol.157 (4), p.599-605
